HIGHLIGHTS
- who: November and colleagues from the University of Helsinki, Finland have published the paper: Evaluation of unsulfated biotechnological chondroitin in a knee osteoarthritis mouse model as a potential novel functional ingredient in nutraceuticals and pharmaceuticals, in the Journal: (JOURNAL)
- what: This work describes for the first time, to the best of the knowledge , the use of biotechnological unsulfated chondroitin in a mouse model of knee OA. In this study, BC was evaluated in_vivo for the first time in mice treated with MIA to resemble pain associated with OA using CS as the control, due to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.